BioMarin Reports Third Quarter 2026 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. RXRX

Go back to BioMarin Reports Third Quarter 2026 Financial and Operating Results

BioMarin Pharma (BMRN) Tops Q3 EPS by 11c

November 2, 2026 4:03 PM EST

BioMarin Pharma (NASDAQ: BMRN) reported Q3 EPS of $0.23, $0.11 better than the analyst estimate of $0.12. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.02 billion.

For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.

... More